- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 28.09. | Glenmark, Granules, Zydus and others recall medicines in US over quality issues: USFDA | 2 | ZEE Business | ||
| 26.09. | Fierce Pharma Asia-Celltrion's Lilly plant buy; Rexulti's PTSD snub; Glenmark, Hengrui's ADC deal | 4 | FiercePharma | ||
| 25.09. | China's Hengrui Rises After Granting India's Glenmark Cancer Drug Rights in Up to USD1.1 Billion Deal | 2 | Yicai Global | ||
| 25.09. | Stock Alert: Glenmark Pharmaceuticals, Lupin, NTPC, Pipavav Port, Newgen | 2 | capitalmarket.com | ||
| 24.09. | In potential $1.1B deal, Glenmark grabs certain rights to Hengrui's ADC rival to Enhertu | 3 | FiercePharma | ||
| 15.09. | Dividendenbekanntmachungen (15.09.2025) | 12.439 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A&W FOOD SERVICES OF CANADA INC CA0002251027 0,48 CAD 0,2954 EUR ALLEGION PLC IE00BFRT3W74 0,51 USD 0,4345 EUR ALTRIA GROUP INC US02209S1033 1... ► Artikel lesen | |
| 08.09. | Glenmark Expands Phase 3 Study of Envafolimab to Multiple Regions | 2 | Mexico Business News | ||
| GLENMARK PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 05.09. | Glenmark Pharmaceuticals: Glenmark Initiates a Multi-Country Phase 3 Clinical Trial for Envafolimab in Resectable Stage III Non-Small Cell Lung Cancer | 298 | PR Newswire | DCGI grants No Objection Certificate to commence enrollment in India
Clinical Trial Applications underway in Russia, Brazil, and Mexico
MUMBAI, India, Sept. 5, 2025 /PRNewswire/... ► Artikel lesen | |
| 05.09. | Glenmark Pharmaceuticals: Glenmark Initiates a Multi-Country Phase 3 Clinical Trial for Envafolimab in Resectable Stage III Non-Small Cell Lung Cancer | 356 | PR Newswire | DCGI grants No Objection Certificate to commence enrollment in India
Clinical Trial Applications underway in Russia, Brazil, and Mexico
MUMBAI, India, Sept. 5, 2025 /PRNewswire/... ► Artikel lesen | |
| 02.09. | Glenmark Pharma's US arm to launch Eribulin Mesylate injection in the US market | 2 | capitalmarket.com | ||
| 20.08. | Alembic, Sun and Glenmark issue US drug recalls due to the presence of carcinogens or foreign matter | 5 | FiercePharma | ||
| 19.08. | Glenmark Pharma's US arm to launch Micafungin injection in the US market | 2 | capitalmarket.com | ||
| 18.08. | Glenmark Pharma shares tumble despite market-wide rally post-Q1 results | 2 | ZEE Business | ||
| 18.08. | Glenmark Pharma, HDFC Bank among 10 stocks that showed RSI Trending Up on August 14 | 3 | Times of India | ||
| 06.08. | Glenmark Pharmaceuticals Subsidiary Reaches $37.75 Million Settlement in US Antitrust Case | 3 | CPI | ||
| 28.07. | Glenmark Pharmaceuticals Ltd spurts 1.22%, up for third straight session | 3 | capitalmarket.com | ||
| 18.07. | Glenmark stock downgraded to Sell by ICICI Securities despite price target hike | 6 | Investing.com | ||
| 18.07. | ICICI Securities stuft Glenmark-Aktie trotz Kurszielerhöhung auf 'Verkaufen' herab | 3 | Investing.com Deutsch | ||
| 16.07. | Glenmark Pharmaceuticals Ltd up for five straight sessions | 2 | capitalmarket.com | ||
| 14.07. | Glenmark Pharmaceuticals Ltd up for third consecutive session | 2 | capitalmarket.com |
1 2 3 4 Weiter >>
67 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SINOPHARM | 2,027 | +0,20 % | Sinopharm Group-Aktie heute gut behauptet: Aktienwert steigt (2,08 €) | Der Anteilsschein der Sinopharm Group notiert heute ein wenig fester. Zuletzt zahlten Investoren für das Wertpapier 2,08 Euro. Jahreschart der Sinopharm Group Ltd-Aktie, Stand 11.09.2025 Freuen können... ► Artikel lesen | |
| CSPC PHARMA | 1,044 | -1,51 % | CSPC PHARMA (01093): DISCLOSEABLE TRANSACTION - DEEMED DISPOSAL OF EQUITY INTEREST IN CSPC INNOVATION ARISING FROM THE PROPOSED LISTING OF THE H SHARES ... | ||
| WUXI BIOLOGICS | 4,673 | +1,16 % | WuXi Biologics-Aktie leicht im Plus (4,441 €) | Das Wertpapier von WuXi Biologics notiert heute fester. Das Papier kostete zuletzt 4,44 Euro. Ein Preisanstieg in Höhe von 17 Cent erfreut derzeit die Aktionäre von WuXi Biologics. Zur Stunde kostet... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 2,792 | -2,58 % | FOSUN PHARMA (02196): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTION | ||
| GEDEON RICHTER | 25,500 | -3,04 % | Gedeon Richter Plc.: Voting rights, registered capital | ||
| DR REDDYS | 12,200 | 0,00 % | Esperion Therapeutics, Inc.: Esperion Reaches Settlement Agreement with ANDA Filer, Dr. Reddy's Laboratories, Not to Market Generic Versions of NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) Prior ... | ANN ARBOR, Mich., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that it has entered into a settlement agreement with Dr. Reddy's Laboratories, Inc. and its affiliate Dr.... ► Artikel lesen | |
| ASPEN PHARMACARE | 4,820 | 0,00 % | Dividendenbekanntmachungen (01.10.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACRES COMMERCIAL REALTY CORP PFD D US00489Q3002 0,4921 USD 0,4193 EUR AECOM US00766T1007 0,26 USD 0,2215 EUR AFRICAN RAINBOW MINERALS... ► Artikel lesen | |
| SHANGHAI PHARMACEUTICALS | 1,390 | +4,51 % | Dividendenbekanntmachungen (16.07.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACERINOX SA ES0132105018 - 0,31 EUR ALAMO GROUP INC US0113111076 0,3 USD 0,2586 EUR APOGEE ENTERPRISES INC US0375981091 0,26 USD 0... ► Artikel lesen | |
| LUYE PHARMA | 0,382 | 0,00 % | LUYE PHARMA (02186): INTERIM REPORT 2025 | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,206 | -0,96 % | SIHUAN PHARM (00460): UPDATE ON THE PROPOSED SPIN-OFF AND SEPARATE LISTING OF XUANZHU BIOPHARM ON THE MAIN BOARD OF THE STOCK EXCHANGE OF HONG KONG LIMITED ... | ||
| CHINA SHINEWAY PHARMACEUTICAL GROUP | 0,900 | +0,56 % | Dividendenbekanntmachungen (09.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALUMINUM CORPORATION OF CHINA LTD CNE1000001T8 0,1348 HKD 0,0147 EUR AMEREN CORPORATION US0236081024 0,71 USD 0,6037 EUR ANHUI... ► Artikel lesen | |
| CHINA RESOURCES PHARMACEUTICAL | 0,515 | -2,83 % | Dividendenbekanntmachungen (11.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACADEMY SPORTS AND OUTDOORS INC US00402L1070 0,13 USD 0,1111 EUR ACTIA GROUP SA FR0000076655 - 0,12 EUR ADT INC US00090Q1031 0... ► Artikel lesen | |
| HANSOH PHARMACEUTICAL | 4,200 | 0,00 % | UBS Downgrades CSPC PHARMA/KELUN PHARM to Neutral, Changes Sector Top Pick to HANSOH PHARMA | ||
| KALBE FARMA | 0,051 | 0,00 % | Ferdinand Aryanto spends IDR 401 million to buy KLBF shares: KLBF commissioner buys 340,000 shares for IDR 401.85 ... | ||
| YICHANG HEC CHANGJIANG PHARMACEUTICAL | - | - | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT UPDATE REGARDING CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BY SUNSHINE LAKE ... |
Das Unternehmen GLENMARK PHARMACEUTICALS LTD kann der Branche Pharma zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLENMARK PHARMACEUTICALS LTD finden Sie auf Wallstreet Online.